Interim trial results show that hydroxychloroquine and lopinavir/ritonavir produce little or no reduction in the mortality of hospitalized #COVID19 patients when compared to the existing standard of care.
— World Health Organization (WHO) (@WHO) July 4, 2020
More https://t.co/dCxHqBIwtr#coronavirus